Literature DB >> 16176212

Fulminant lactic acidosis in two patients with Type 2 diabetes treated with metformin.

R Brassøe1, T Elkmann, M Hempel, C H Gravholt.   

Abstract

Lactic acidosis is a known adverse risk of metformin treatment. We report two cases in whom fulminant lactic acidosis developed during treatment. There were no contraindications to metformin treatment and both were admitted with abdominal discomfort for some days, causing dehydration. Both patients had renal failure on admission, developed multiple organ failure and both suffered a massive stroke. One patient died and the other survived but is severely disabled. We suggest, in both cases, that acute renal failure developed as a result of dehydration, causing metformin accumulation and lactic acidosis. We recommend that all patients on metformin should consider discontinuation of metformin treatment in the event of a severe medical condition causing dehydration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176212     DOI: 10.1111/j.1464-5491.2005.01650.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  5 in total

1.  The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis.

Authors:  Janna K Duong; Timothy J Furlong; Darren M Roberts; Garry G Graham; Jerry R Greenfield; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

2.  The Association between Metformin Therapy and Lactic Acidosis.

Authors:  Isabelle H S Kuan; Ruth L Savage; Stephen B Duffull; Robert J Walker; Daniel F B Wright
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

3.  Prescribing metformin in type 2 diabetes with a contraindication: prevalence and outcome.

Authors:  Juraporn Pongwecharak; Nawatsanan Tengmeesri; Nongluck Malanusorn; Matshamon Panthong; Nantida Pawangkapin
Journal:  Pharm World Sci       Date:  2009-05-22

4.  Clinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia.

Authors:  Nada F Zaki; Azhar S Sulaiman; Wasif S Gillani
Journal:  Int Arch Med       Date:  2010-11-24

5.  Is it necessary to discontinue metformin in diabetic patients with GFR > 60 ml/min per 1.73 m2 undergoing coronary angiography: A controversy still exists?

Authors:  Mohammad Hasan Namazi; Saeed AlipourParsa; Kobra Roohigilani; Morteza Safi; Hossein Vakili; Isa Khaheshi; Fatemeh Abdi; Adel Zare; Shooka Esmaeeli
Journal:  Acta Biomed       Date:  2018-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.